Bartlett & Co’s LeMaitre Vascular LMAT Stock Holding History

Bartlett & Co’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-27	Closed	-$1K	–	1120
2020 Q4	$1K	Buy	+27	New	+$965	﹤0.01%	1025

Other funds holding LMAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

SCA

Summit Creek Advisors Minneapolis, Minnesota $487M AUM 11.23% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Bartlett & Co's LMAT Position: Q1 2021 in Review

Bartlett & Co sold out of LeMaitre Vascular (LMAT) in Q1 2021, closing a stake of 27 shares — an estimated $1K sold.

Bartlett & Co first reported a position in LMAT in Q4 2020 and held it in 1 quarter. The position peaked at $1K in Q4 2020. 179 funds tracked by Wall St. Rank hold LMAT as of Q1 2021.

Bartlett & Co reported no remaining LeMaitre Vascular position as of Q1 2021 after selling out during the quarter.
Bartlett & Co sold 27 LeMaitre Vascular shares in Q1 2021, an estimated $1K.
Bartlett & Co first reported a position in LeMaitre Vascular in Q4 2020 and held it in 1 quarter.
Bartlett & Co's LeMaitre Vascular position peaked at $1K in Q4 2020.
179 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2021.

Based on Bartlett & Co's 13F filing for Q1 2021, filed 19 Apr 2021.